This new analysis presented at ECO, focused on the difference in early cardiovascular events with semaglutide versus placebo from randomisation up to 12 months, with a focus on 3 and 6 months, to better understand the drugs effects, time to cardiovascular benefit, as well as predictors that might help identify patients at risk for early cardiovascular events
Find Your Protein daily targets by body weight, 100 to 400 lbs Drink Your Water hydration targets calibrated for GLP-1 patients Includes clinical references
Si las personas dejan de tomar la medicacin, es probable que muchas necesiten apoyo nutricional y conductual continuo, y los servicios de salud deben anticipar que los beneficios cardiometablicos pueden disminuir a medida que se recupera el peso, dijo Spreckley, agregando que esto resalta la necesidad de ms investigacin sobre estrategias eficaces y escalables para el mantenimiento del peso a largo plazo junto con la farmacoterapia
Avoid taking more than one paracetamol-containing product at the same time, and seek medical advice for long-term regular use